Malken Bayrakdarian - Concepedia

Author

Malken Bayrakdarian

Université de Montréal

Also Known As

M. Bayrakdarian, Malken Bayrakdarian

Publications

474

Citations

H-Index

Concepts

All Affiliations

Université de Montréal AstraZeneca (Canada)Novartis (Switzerland)AstraZeneca (Sweden)AstraZeneca (United Kingdom)

About

Malken Bayrakdarian is an author at Université de Montréal specializing in natural sciences, pharmacology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	10	10	359
2	Medicine	8	8	287
3	Biochemistry	7	7	269
4	Engineering	6	6	158
5	Health Sciences	1	1	30

Malken Bayrakdarian

Publications

468

Citations

H-Index

Page 1

	Year	Citations
Total Synthesis of A-315675: A Potent Inhibitor of Influenza Neuraminidase Stephen Hanessian, Malken Bayrakdarian, Xuehong Luo Journal of the American Chemical Society Combinatorial ChemistryMedicinal ChemistryBioorganic ChemistryCyclic MotifsBiochemistry	2002	82
Structure-Based Design, Synthesis, and Memapsin 2 (BACE) Inhibitory Activity of Carbocyclic and Heterocyclic Peptidomimetics Stephen Hanessian, Hongying Yun, Yihua Hou, Journal of Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryBiochemistryNatural SciencesMedicine	2005	72
Structural and NMR Studies of Indenyl Hapticity and Rotational Barriers in the Complexes <b>(</b>η-1-R-Indenyl)Ni(PPh<sub>3</sub>)(X) (R = H, Me; X = Cl, Me) Trisha A. Huber, Malken Bayrakdarian, Sylvain Dion, Organometallics Inorganic ChemistryIndenyl HapticityEngineeringNatural SciencesCoordination Complex	1997	59
Discovery of P2X3 selective antagonists for the treatment of chronic pain Louis‐David Cantin, Malken Bayrakdarian, Christophe Buon, Bioorganic & Medicinal Chemistry Letters Pain TherapyHealth SciencesPain MedicineP2x3 Selective AntagonistsPain Treatment	2012	30
Design, synthesis, and thrombin-inhibitory activity of pyridin-2-ones as P2/P3 core motifs Stephen Hanessian, Daniel Simard, Malken Bayrakdarian, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBioorganic ChemistryBiochemistryNatural SciencesMedicine	2008	27
Design and Synthesis of a Novel Class of Constrained Tricyclic Pyrrolizidinone Carboxylic Acids as Carbapenem Mimics Stephen Hanessian, Ronald N. Buckle, Malken Bayrakdarian The Journal of Organic Chemistry Combinatorial ChemistryEngineeringAntibacterial ActivityOrganic ChemistryChemistry	2002	27
Discovery and Pharmacological Characterization of a Small-Molecule Antagonist at Neuromedin U Receptor NMUR2 Jay Liu, Kemal Payza, Jian Huang, Journal of Pharmacology and Experimental Therapeutics	2009	23
Reactive Metabolite Trapping Screens and Potential Pitfalls: Bioactivation of a Homomorpholine and Formation of an Unstable Thiazolidine Adduct Eva M. Lenz, Scott Martin, Ralf Schmidt, Chemical Research in Toxicology Pharmaceutical ScienceNmr SpectroscopySecondary MetaboliteChemical BiologyPharmaceutical Chemistry	2014	23
Pyrrolidine as a cogwheel-like scaffold for the deployment of diverse functionality through cycloaddition reactions of metallo-1,3-dipoles in aqueous media Stephen Hanessian, Malken Bayrakdarian Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryChemical EngineeringNovel OrganocatalystsEngineeringOrganic Chemistry	2000	21
Solution- and solid-phase asymmetric synthesis of substituted N-hydroxypyrrolidine dicarboxylic acids Stephen Hanessian, Malken Bayrakdarian Tetrahedron Letters EngineeringSolid-phase Asymmetric SynthesisOrganic ChemistryStereoselective SynthesisChemistry	2002	20

Page 1